Multifunctional Nanodelivery Platform for Maximizing Nucleic Acids Combination Therapy.
Animals
Cell Line, Tumor
Drug Carriers
/ chemistry
Drug Delivery Systems
Female
Gold
/ chemistry
Humans
Hyaluronic Acid
/ chemistry
Mice, Inbred BALB C
Mice, Nude
Nanoparticles
/ chemistry
Neoplasms
/ genetics
Peptides
/ chemistry
RNA, Small Interfering
/ administration & dosage
RNAi Therapeutics
/ methods
Static Electricity
Combination therapy
Electrostatic interactions
Gold nanoparticles
Hyaluronic acid
KLA peptide
Layer-by-layer
Nucleic acids
Poly-L-lysine
Small interfering RNA
microRNA
Journal
Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969
Informations de publication
Date de publication:
2020
2020
Historique:
entrez:
2
2
2020
pubmed:
2
2
2020
medline:
2
2
2021
Statut:
ppublish
Résumé
The silencing of an oncogene with a small interfering RNA (siRNA) is a promising way for cancer therapy. Its efficacy can be further enhanced by integrating with other therapeutics; however, transporting siRNA and other active ingredients to the same location at the same time is challenging. Here, we report a novel multifunctional nanodelivery platform by sequentially layering several functional ingredients, such as siRNAs, microRNAs, peptides, and targeting ligands, onto a core through charge-charge interaction. The prepared nanovectors effectively and programmably delivered multiple active components to maximize therapeutic combination with minimal off-targeting effects.
Identifiants
pubmed: 32006395
doi: 10.1007/978-1-0716-0290-4_4
doi:
Substances chimiques
Drug Carriers
0
Peptides
0
RNA, Small Interfering
0
Gold
7440-57-5
Hyaluronic Acid
9004-61-9
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM